Evercore ISI analyst Vijay Kumar raised the firm’s price target on Exact Sciences (EXAS) to $70 from $60 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life ...

Sight Sciences, Inc.'s share price has fallen by -13.3% in the past 3 weeks, despite reporting a narrower-than-expected net loss in Q1 and sticking to its 2023 guidance. Sight Sciences' key Q1 2023 ...

180 Life Sciences (ATNF) announced that it has entered into a securities purchase agreement with several institutional investors to sell 1,200,000 shares of common stock in a registered direct ...

) has been revised to $9.54 / share. This is an increase of 19.11% from the prior estimate of $8.01 dated December 18, 2025. The price target is an average of many targets provided by analysts. The ...

BTIG analyst Mark Massaro lowered the firm’s price target on Exact Sciences (EXAS) to $65 from $82 and keeps a Buy rating on the shares. The company delivered a Q3 revenue miss and large guide-down, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

View Caris Life Sciences, Inc. CAI stock quote prices, financial information, real-time forecasts, and company news from CNN.

The average one-year price target for ENDRA Life Sciences (NasdaqCM:NDRA) has been revised to $27.54 / share. This is a decrease of 10.00% from the prior estimate of $30.60 dated April 7, 2026. The ...

What's Sai Life Sciences Ltd share price today. Get Sai Life Sciences Ltd latest news on BSE/NSE stock price live updates, Sai Life Sciences Ltd financial results and overview, Sai Life Sciences Ltd ...